Effect of blood collection time on measured δ9-Tetrahydrocannabinol concentrations: Implications for driving interpretation and drug policy

Clinical Chemistry

Volumn 62, Issue 2, 2016, Pages 367-377

  Hartman, Rebecca L ^a   Brown, Timothy L ^b   Milavetz, Gary ^b   Spurgin, Andrew ^b   Gorelick, David A ^a,c   Gaffney, Gary R ^d   Huestis, Marilyn A ^a,e  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF IOWA   (United States)

^e Biomedical Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CANNABIS; DRONABINOL;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; DRIVE; DRUG BLOOD LEVEL; DRUNKEN DRIVING; FEMALE; HUMAN; MALE; MAXIMUM PLASMA CONCENTRATION; TIME; BLOOD; BLOOD ANALYSIS; CANNABIS SMOKING; CAR DRIVING; CONTROLLED STUDY; FORENSIC MEDICINE; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; SUBSTANCE ABUSE; TIME FACTOR; TRAFFIC ACCIDENT; YOUNG ADULT;

ACCIDENTS, TRAFFIC; ADULT; AUTOMOBILE DRIVING; BLOOD CHEMICAL ANALYSIS; BLOOD SPECIMEN COLLECTION; DRONABINOL; ETHANOL; FEMALE; FORENSIC MEDICINE; HUMANS; MALE; MARIJUANA SMOKING; SUBSTANCE ABUSE DETECTION; TIME FACTORS; YOUNG ADULT;

EID: 84957055418     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2015.248492     Document Type: Article

References (40)

1. Berning A, Compton R, Wochinger K. Results of the 2013-2014 National Roadside Survey of Alcohol and Drug Use by Drivers. Traffic Safety Facts: Research Note. Washington (DC): National Highway Traffic Safety Administration; 2015. Paper 812-118.
2. Legrand SA, Isalberti C, Van der Linden T, Bernhoft IM, Hels T, Simonsen KW, et al. Alcohol and drugs in seriously injured drivers in six European countries. Drug Test Anal 2013;5:156-65.
3. Li MC, Brady JE, DiMaggio CJ, Lusardi AR, Tzong KY, Li G. Marijuana use and motor vehicle crashes. Epidemiol Rev 2012;34:65-72.
4. Asbridge M, Hayden JA, Cartwright JL. Acute cannabis consumption and motor vehicle collision risk: systematic review of observational studies and meta-analysis. BMJ 2012;344:e536.
5. Biecheler MB, Peytavin JF, Facy F, Martineau H. SAM survey on "Drugs and fatal accidents": search of substances consumed and comparison between drivers involved under the influence of alcohol or cannabis. Traffic Inj Prev 2008;9:11-21.
6. Jones AW, Holmgren A, Kugelberg FC. Driving under the influence of cannabis: A 10-year study of age and gender differences in the concentrations of tetrahydrocannabinol in blood. Addiction 2008;103:452- 61.
7. Baggio S, Deline S, Studer J, Mohler-Kuo M, Daeppen JB, Gmel G. Routes of administration of cannabis used for nonmedical purposes and associations with patterns of drug use. J Adolesc Health 2014;54:235- 40.
8. Huestis MA, Henningfield JE, Cone EJ. Blood cannabinoids I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana. J Anal Toxicol 1992;16:276 - 82.
9. Huestis MA. Pharmacokinetics and metabolism of the plant cannabinoids, Delta9-tetrahydrocannabinol, cannabidiol and cannabinol. Handb Exp Pharmacol 2005; 168:657-90.
10. Hartman RL, Brown TL, Milavetz G, Spurgin A, Gorelick DA, Gaffney G, Huestis MA. Controlled cannabis vaporizer administration: blood and plasma cannabinoids with and without alcohol. Clin Chem 2015;61:850 - 69.
11. Desrosiers NA, Himes SK, Scheidweiler KB, Concheiro-Guisan M, Gorelick DA, Huestis MA. Phase I and II cannabinoid disposition in blood and plasma of occasional and frequent smokers following controlled smoked cannabis. Clin Chem 2014;60:631- 43.
12. Karschner E, Schwilke E, Lowe R, Darwin W, Pope H Jr, Herning R, et al. Do Delta9-tetrahydrocannabinol concentrations indicate recent use in chronic cannabis users? Addiction 2009;104:2041- 8.
13. Bergamaschi MM, Karschner EL, Goodwin RS, Scheidweiler KB, Hirvonen J, Queiroz RH, Huestis MA. Impact of prolonged cannabinoid excretion in chronic daily cannabis smokers' blood on per se drugged driving laws. Clin Chem 2013;59:519 -26.
14. Armentano P. Should per se limits be imposed for cannabis? Equating cannabinoid blood concentrations with actual driver impairment: practical limitations and concerns. Humboldt J Soc Relat 2013;35:45-55.
15. Ingold J. Driving while stoned difficult to define, regulate in Colorado. Denver (CO): The Denver Post; 2011.
16. Moreno I. Colorado medical marijuana users sound off on bill that would limit THC levels for drivers. New York: The Huffington Post; 2011.
17. Urfer S, Morton J, Beall V, Feldmann J, Gunesch J. Analysis of Delta9-tetrahydrocannabinol driving under the influence of drugs cases in Colorado from January 2011 to February 2014. J Anal Toxicol 2014;38:575- 81.
18. ProCon.org. 23 Legal medical marijuana states and DC: laws, fees, andpossessionlimits.http://medicalmarijuana.procon.org/view.resource.php?resourceID=000881 (Accessed December 2014).
19. Salomonsen-Sautel S, Min SJ, Sakai JT, Thurstone C, Hopfer C. Trends in fatal motor vehicle crashes before and after marijuana commercialization in Colorado. Drug Alcohol Depend 2014;140:137- 44.
20. Hartman RL, Brown TL, Milavetz G, Spurgin A, Gorelick DA, Gaffney G, Huestis MA. Cannabis effects on driving lateral control with and without alcohol. Drug Alcohol Depend 2015;154:25-37.
21. Adamson SJ, Sellman JD. A prototype screening instrument for cannabis use disorder: The cannabis use disorders identification test (CUDIT) in an alcoholdependent clinical sample. Drug Alcohol Rev 2003;22: 309 -15.
22. Sobell LC, Sobell MB. Alcohol consumption measures. In: Allen JP, Wilson VB, editors. Assessing alcohol problems: A guide for clinicians and researchers, 2nd ed. Bethesda (MD): National Institute on Alcohol Abuse and Alcoholism, NIH; 2003:75-99.
23. Lee JD, Fiorentino D, Reyes ML, Brown TL, Ahmad O, Fell J, et al. Assessing the feasibility of vehicle-based sensors to detect alcohol impairment. Washington (DC): National Highway Traffic Safety Administration; 2010. Paper 811-358.
24. Garrott WR, Mazzae EN, Goodman MJ. NHTSA's National Advanced Driving Simulator research program. Washington (DC): National Highway Traffic Safety Administration; 2005. Paper 05-0377.
25. Scheidweiler KB, Schwope DM, Karschner EL, Desrosiers NA, Gorelick DA, Huestis MA. In vitro stability of free and glucuronidated cannabinoids in blood and plasma following controlled smoked cannabis. Clin Chem 2013;59:1108 -17.
26. Schwope D, Scheidweiler K, Huestis M. Direct quantification of cannabinoids and cannabinoid glucuronides in whole blood by liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem 2011;401: 1273- 83.
27. Schwope DM, Bosker WM, Ramaekers JG, Gorelick DA, Huestis MA. Psychomotor performance, subjective and physiological effects and whole blood delta9- Tetrahydrocannabinol concentrations in heavy, chronic cannabis smokers following acute smoked cannabis. J Anal Toxicol 2012;36:405-12.
28. Chiang CWN, Barnett G. Marijuana effect and Delta-9- Tetrahydrocannabinol plasma level. Clin Pharmacol Ther 1984;36:234 - 8.
29. Ramaekers JG, Kauert G, van Ruitenbeek P, Theunissen EL, Schneider E, Moeller MR. High-potency marijuana impairs executive function and inhibitory motor control. Neuropsychopharmacology 2006;31:2296 -303.
30. Jones AW. Evidence-based survey of the elimination rates of ethanol from blood with applications in forensic casework. Forensic Sci Int 2010;200:1-20.
31. Caplan YH. Breath alcohol testing: Principles and instrumentation. Medical Review Officer Update. Arlington Heights (IL): American College of Occupational and Environmental Medicine; 1995. p 1-7.
32. Odell MS, Frei MY, Gerostamoulos D, Chu M, Lubman DI. Residual cannabis levels in blood, urine and oral fluid following heavy cannabis use. Forensic Sci Int 2015;249:173- 80.
33. Ramaekers J, Kauert G, Theunissen E, Toennes S, Moeller M. Neurocognitive performance during acute THC intoxication in heavy and occasional cannabis users. J Psychopharmacol 2009;23:266 -77.
34. Ramaekers J, Theunissen E, de Brouwer M, Toennes S, Moeller M, Kauert G. Tolerance and cross-tolerance to neurocognitive effects of THC and alcohol in heavy cannabis users. Psychopharmacology 2011;214:391- 401.
35. Drummer OH, Gerostamoulos J, Batziris H, Chu M, Caplehorn J, Robertson MD, Swann P. The involvement of drugs in drivers of motor vehicles killed in Australian road traffic crashes. Accid Anal Prev 2004;36:239 - 48.
36. Ramaekers JG, Moeller MR, van Ruitenbeek P, Theunissen EL, Schneider E, Kauert G. Cognition and motor control as a function of Delta9-THC concentration in serum and oral fluid: limits of impairment. Drug Alcohol Depend 2006;85:114 -22.
37. Grotenhermen F, Leson G, Berghaus G, Drummer OH, Krüger HP, Longo M, et al. Developing limits for driving under cannabis. Addiction 2007;102:1910 -7.
38. Giroud C, Ménétrey A, Augsburger M, Buclin T, Sanchez-Mazas P, Mangin P. Δ9-THC, 11-OH-Δ9-THC and Δ9-THCCOOH plasma or serum to whole blood concentrations distribution ratios in blood samples taken from living and dead people. Forensic Sci Int 2001;123:159 - 64.
39. Himes SK, Scheidweiler KB, Beck O, Gorelick DA, Desrosiers NA, Huestis MA. Cannabinoids in exhaled breath following controlled administration of smoked cannabis. Clin Chem 2013;59:1780 -9.
40. Hartman RL, Anizan S, Jang M, Brown TL, Yun K, Gorelick D, et al. Cannabinoid disposition in oral fluid after controlled vaporizer administration with and without alcohol. Forensic Toxicol 2015;33:260 -78.